Signals, Powered By EquityPandit
Himalaya Drug Company, a herbal wellness major aims to double its sales turnover to Rs 4,000 crore in the next four years.
Philipe Haydon, the CEO of the company said that “We are looking at doubling our turnover to Rs 4,000 crore from Rs 2,000 crore at present in the next four years. We will register a CAGR of 20-25 percent over the next four years. Our growth drivers will be wellness, baby care and personal care products.”
Detailing on the wellness range of the company, he further said that “Wellness portfolio is the fastest growing vertical in our company…we are looking at creating and defining wellness category in India. We will aggressively promote our wellness products as we truly believe it has the potential to revolutionise health management in India.”
